Clinical Trial Update: Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether altering gut bacterial androgen production can overcome resistance to Abiraterone in patients with metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Zytiga) (abiraterone acetate)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer (Adenocarcinoma), Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING